Beste apotheek van Nederland

Kirby R S. Report from London. Prostate Cancer & Prostatic
Diseases 2005;8(4):299
Kirby R S, Andersen M, Gratzke P et al. A combined analysis of
double-blind trials of the efficacy and tolerability of doxazosingastrointestinal
therapeutic system, doxazosin standard and
placebo in patients with benign prostatic hyperplasia. BJU Int
2001;87(3):192-200.
Kirby R S, O'Leary M P, Carson C. Efficacy of extended-release
doxazosin and doxazosin standard in patients with concomitant
benign prostatic hyperplasia and sexual dysfunction.. BJU Int
2005;95(1):103-109.
Kiriakova N, Kiriakov A, Schneider E et al. Therapeutic effect
of essential phospholipids on functional sexual disorders in
males. Journal of the European Academy of Dermatology &
Venereology 1998;11(2):191-193.
Kleinberg D L, Davis J M, De Coster R et al. Prolactin levels
and adverse events in patients treated with risperidone.[see
comment]. J Clin Psychopharmacol 1999;19(1):57-61.
Kley H K, Stremmel W, Kley J B et al. Testosterone treatment
of men with idiopathic hemochromatosis. Clin Investig
1992;70(7):566-572.
Kloner R A. Cardiovascular risk and sildenafil. [Review] [27
refs]. Am J Cardiol 2000;86(2A):57F-61F.
Kloner R A, Zusman R M. Cardiovascular effects of sildenafil
citrate and recommendations for its use. [Review] [21 refs]. Am
J Cardiol 1999;84(5B):11N-17N.
Kloner R A, Brindis R G, Cheitlin M D et al. Roundtable
discussion: Tadalafil study group. Am J Cardiol 2003;92(9
SUPPL. 1):58M-65M.
Kloner R A, Hutter A M, Emmick J T et al. Time course of the
interaction between tadalafil and nitrates.[see comment]. J Am
Coll Cardiol 2003;42(10):1855-1860.
Kloner R A, Jackson G, Emmick J T et al. Interaction between
the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers,
doxazosin and tamsulosin in healthy normotensive men. Br J
Urol 2004;172(5:Pt 1):t-40.
Kloner R A, Mitchell M, Emmick J T. Cardiovascular effects of
tadalafil in patients on common antihypertensive therapies.
[Review] [5 refs]. Am J Cardiol 2003;92(9A):47M-57M.
Kloner R A, Mitchell M, Emmick J T. Cardiovascular effects of
tadalafil. [Review] [12 refs]. Am J Cardiol 2003;92(9A):37M­
46M.
Klotz T, Mathers M J, Braun M et al. Effectiveness of oral L-
arginine in first-line treatment of erectile dysfunction in a
controlled crossover study. Urol Int 1999;63(4):220-223.
Knegtering R, Castelein S, Bous H et al. A Randomized Open-
Label Study of the Impact of Quetiapine Versus Risperidone on
Sexual Functioning. J Clin Psychopharmacol 2004;24(1):56-61.
Knispel H H. Penile venous surgery in impotence:
results in highly selected cases. Urol Int
1991;47(3):144-148.
Knoll L D, Benson R C, Bilhartz D L et al. A
randomized crossover study using yohimbine and
isoxsuprine versus pentoxifylline in the management
of vasculogenic impotence.. Br J Urol
1996;155(1):144-146.
Kobayashi T, Okuno H, Nishiyama H et al. Adultonset
idiopathic hypogonadotropic hypogonadism
presented with erectile and ejaculatory disorder. Int J
Urol 2002;9(10):604-606.
Kramer-Levien D J. Papaverine--the medical implant.
AUAA J 1987;7(4):13-Jun.
Krause W, Mueller U, Mazur A. Measurement of
steroid levels in saliva in a population-based survey of
lifestyle, medical conditions, marriage, sex life and
hormone status in aging men: A feasibility study.
Aging Male 2002;5(4):203-215.
Kriston L, Harms A, Berner M M. A meta-regression
analysis of treatment effect modifiers in trials with
flexible-dose oral sildenafil for erectile dysfunction in
broad-spectrum populations. Int J Impot Res
2006;18(6):559-565.
Kromann-Andersen B. Intracavernosal
pharmacotherapy with injection pen. Lancet
1988;1(8575-6):54-59.
Kuba R, Pohanka M, Zakopcan J et al. Sexual
dysfunctions and blood hormonal profile in men with
focal epilepsy. Epilepsia 2006;47(12):2135-2140.
Kukreja R C, Ockaili R, Salloum F et al.
Cardioprotection with phosphodiesterase-5 inhibition ­
A novel preconditioning strategy. Journal of
Molecular & Cellular Cardiology 2004;36(2):165-173.
Kunelius P, Hakkinen J, Lukkarinen O. Is high-dose
yohimbine hydrochloride effective in the treatment of
mixed-type impotence? A prospective, randomized,
controlled double-blind crossover study. Urology
1997;49(3):441-444.
Kupecz D. Alprostadil for the treatment of erectile
dysfunction. J Am Acad Nurse Pract 1996;21(5):143­
145.
Kupelian V, Shabsigh R, Travison T G et al. Is there a
relationship between sex hormones and erectile
dysfunction? Results from the Massachusetts Male
Aging Study. Br J Urol 2006;176(6 Pt 1):2584-2588.
Kvistborg A, Halse J, Bakke S et al. Long-term
treatment of macroprolactinomas with CV 205-502.
Acta Endocrinol (Copenh) 1993;128(4):301-307.
D-139